100 ML idecabtagene vicleucel 5100000 CELLS/ML Injection — RxCUI 2536449
RxNorm drug concept · Semantic clinical drug
RxCUI 2536449
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2536449
Official name100 ML idecabtagene vicleucel 5100000 CELLS/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asidecabtagene vicleucel 5100000 CELLS/ML per 100 ML Injection; idecabtagene vicleucel 510,000,000 CELLS in 100 ML Injection; idecabtagene vicleucel 510,000,000 CELLS per 100 ML Injection
FDA products mapped1
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Idecabtagene Vicleucel Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Abecma is made from your own immune cells — specifically your T cells. Doctors collect them, genetically engineer them in a lab to recognize and destroy your myeloma cells, and the...
- What exactly is Abecma and how is it different from regular chemotherapy?
- The most serious one is called cytokine release syndrome, or CRS — it happened in almost 9 out of 10 patients in studies. It can feel like a severe flu with high fever, low blood p...
- What are the most important side effects I should know about?
🕸️ Concept Web — How 100 ML idecabtagene vicleucel 5100000 CELLS/ML I... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
100 ML idecabtagene vicleucel 5100000 CELLS/ML Injection
RxCUI 2536449 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Idecabtagene vicleucel
2536430IN
-
Idecabtagene vicleucel
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Abecma
2536435BN
-
Abecma
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Idecabtagene vicleucel Injection
2536433SCDF -
Idecabtagene vicleucel Injectable Product
2536432SCDG -
Idecabtagene vicleucel Injection [Abecma]
2536437SBDF -
Abecma Injectable Product
2536438SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Idecabtagene vicleucel Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Idecabtagene vicleucel 5100000 CELLS/ML
2707601SCDC -
100 ML idecabtagene vicleucel 5100000 CELLS/ML Injection [Abecma]
2536451SBD -
Idecabtagene vicleucel 5100000 CELLS/ML [Abecma]
2707604SBDC
-
Idecabtagene vicleucel 5100000 CELLS/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Idecabtagene vicleucel 5100000 CELLS/ML
SCDC · 2707601 -
Idecabtagene vicleucel Injection
SCDF · 2536433 -
Idecabtagene vicleucel Injectable Product
SCDG · 2536432
Brand-Name Concepts
-
100 ML idecabtagene vicleucel 5100000 CELLS/ML Injection [Abecma]
SBD · 2536451 -
Idecabtagene vicleucel 5100000 CELLS/ML [Abecma]
SBDC · 2707604 -
Idecabtagene vicleucel Injection [Abecma]
SBDF · 2536437 -
Abecma Injectable Product
SBDG · 2536438 -
Abecma
BN · 2536435
📦 FDA Products & Package NDCs
1 product · 3 package NDCs
3 package NDCs map to RxCUI 2536449 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 59572-0515-01 | 1 SUSPENSION in 1 BAG (59572-515-01) | Abecma | Celgene Corporation | 2021-03-26 |
| 59572-0515-02 | 1 SUSPENSION in 1 BAG (59572-515-02) | Abecma | Celgene Corporation | 2021-03-26 |
| 59572-0515-03 | 1 SUSPENSION in 1 BAG (59572-515-03) | Abecma | Celgene Corporation | 2021-03-26 |
Observed labelers:
Celgene Corporation (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| Q2055 | Idecabtagene vicleucel car | 3 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.